# World Hypertension League perspective on public health initiatives to reduce global sodium consumption: are we not seeing the elephant in the room?

**Authors:** Francesco P. Cappuccio

PMC · DOI: 10.1038/s41371-025-01075-9 · Journal of Human Hypertension · 2025-10-14

## TL;DR

This paper discusses the use of low-sodium salt substitutes to reduce cardiovascular disease risks, but highlights that benefits may come from increased potassium rather than sodium reduction.

## Contribution

The paper emphasizes the need to focus on direct sodium reduction in global public health strategies despite the potential benefits of potassium from salt substitutes.

## Key findings

- Trials in Peru and China showed improved blood pressure and CVD outcomes with low-sodium salt substitutes.
- Observed benefits were likely due to increased potassium intake rather than reduced sodium consumption.
- Current WHO guidance on salt substitutes remains conditional due to uncertainties and limited population studies.

## Abstract

Sodium reduction is a well-established strategy for the prevention of cardiovascular disease (CVD), yet effective implementation requires context-specific approaches. Low-sodium salt substitutes (LSSS), in which sodium chloride is partially replaced with potassium chloride, have been investigated as an adjunct intervention. Evidence from randomized controlled trials in Peru and China demonstrates substantial increases in potassium intake and corresponding improvements in blood pressure and CVD outcomes. However, reductions in sodium intake were modest or absent, suggesting that the observed benefits are mediated primarily by potassium rather than sodium reduction. Additional concerns include compensatory sodium consumption from alternative sources, limited evaluation beyond high-risk cohorts, and uncertain safety in populations excluded from trials, such as individuals with kidney disease, children, and pregnant women. Current World Health Organization guidance remains ‘conditional’, reflecting these uncertainties. While LSSS may contribute to CVD prevention strategies, the central objective of global policy continues to be the sustained reduction of population sodium intake.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995), kidney disease (MONDO:0001343)

## Full-text entities

- **Diseases:** Hypertension (MESH:D006973)
- **Chemicals:** sodium (MESH:D012964)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12592213/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12592213/full.md

---
Source: https://tomesphere.com/paper/PMC12592213